325 related articles for article (PubMed ID: 24712500)
1. Biologic therapy in asthma: entering the new age of personalized medicine.
Fajt ML; Wenzel SE
J Asthma; 2014 Sep; 51(7):669-76. PubMed ID: 24712500
[TBL] [Abstract][Full Text] [Related]
2. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
Fajt ML; Wenzel SE
J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
[TBL] [Abstract][Full Text] [Related]
3. Biologic targeted therapy in allergic asthma.
Bice JB; Leechawengwongs E; Montanaro A
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):108-15. PubMed ID: 24468249
[TBL] [Abstract][Full Text] [Related]
4. Targeting the interleukin pathway in the treatment of asthma.
Chung KF
Lancet; 2015 Sep; 386(9998):1086-96. PubMed ID: 26383000
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of anti-IL-1β IgY in guinea pigs with allergic asthma induced by ovalbumin.
Wei-xu H; Qin X; Zhu W; Yuan-yi C; Li-feng Z; Zhi-yong L; Dan H; Xiao-mu W; Guo-zhu H
Mol Immunol; 2014 Mar; 58(1):139-49. PubMed ID: 24355520
[TBL] [Abstract][Full Text] [Related]
6. Future biologic therapies in asthma.
Quirce S; Bobolea I; Domínguez-Ortega J; Barranco P
Arch Bronconeumol; 2014 Aug; 50(8):355-61. PubMed ID: 24685200
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB
Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Kim SH; Hong JH; Lee YC
Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma.
Chung F
Mediators Inflamm; 2001 Apr; 10(2):51-9. PubMed ID: 11405550
[TBL] [Abstract][Full Text] [Related]
10. Individual cytokines contributing to asthma pathophysiology: valid targets for asthma therapy?
Chung KF
Curr Opin Investig Drugs; 2003 Nov; 4(11):1320-6. PubMed ID: 14758771
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma.
Liu X; Li M; Wu Y; Zhou Y; Zeng L; Huang T
Biochem Biophys Res Commun; 2009 Aug; 386(1):181-5. PubMed ID: 19508862
[TBL] [Abstract][Full Text] [Related]
12. The etiologies, pathophysiology, and alternative/complementary treatment of asthma.
Miller AL
Altern Med Rev; 2001 Feb; 6(1):20-47. PubMed ID: 11207455
[TBL] [Abstract][Full Text] [Related]
13. Synergistic therapeutic effects of combined adenovirus-mediated interleukin-10 and interleukin-12 gene therapy on airway inflammation in asthmatic mice.
Hsu CY; Liu HE; Sheu FY; Leu SJ; Chiang BL; Hsiao G; Lee YL
J Gene Med; 2010 Jan; 12(1):11-21. PubMed ID: 19866481
[TBL] [Abstract][Full Text] [Related]
14. Anti-interleukin therapy in asthma.
Dunn RM; Wechsler ME
Clin Pharmacol Ther; 2015 Jan; 97(1):55-65. PubMed ID: 25670383
[TBL] [Abstract][Full Text] [Related]
15. Cytokine gene-modulated dendritic cells protect against allergic airway inflammation by inducing IL-10(+)IFN-gamma(+)CD4(+) T cells.
Hsu CY; Leu SJ; Chiang BL; Liu HE; Su HC; Lee YL
Gene Ther; 2010 Aug; 17(8):1011-21. PubMed ID: 20357831
[TBL] [Abstract][Full Text] [Related]
16. A single administration of interleukin-4 antagonistic mutant DNA inhibits allergic airway inflammation in a mouse model of asthma.
Nishikubo K; Murata Y; Tamaki S; Sugama K; Imanaka-Yoshida K; Yuda N; Kai M; Takamura S; Sebald W; Adachi Y; Yasutomi Y
Gene Ther; 2003 Dec; 10(26):2119-25. PubMed ID: 14625566
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
[TBL] [Abstract][Full Text] [Related]
18. Contributing factors to the pathobiology of asthma. The Th1/Th2 paradigm.
Colavita AM; Reinach AJ; Peters SP
Clin Chest Med; 2000 Jun; 21(2):263-77, viii. PubMed ID: 10907587
[TBL] [Abstract][Full Text] [Related]
19. Role of IL-23-Th17 cell axis in allergic airway inflammation.
Wakashin H; Hirose K; Iwamoto I; Nakajima H
Int Arch Allergy Immunol; 2009; 149 Suppl 1():108-12. PubMed ID: 19494515
[TBL] [Abstract][Full Text] [Related]
20. Anti-IL-4/-13 based therapy in asthma.
Walsh GM
Expert Opin Emerg Drugs; 2015 Sep; 20(3):349-52. PubMed ID: 26021492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
